1,874 research outputs found
Deep Learning in Cardiology
The medical field is creating large amount of data that physicians are unable
to decipher and use efficiently. Moreover, rule-based expert systems are
inefficient in solving complicated medical tasks or for creating insights using
big data. Deep learning has emerged as a more accurate and effective technology
in a wide range of medical problems such as diagnosis, prediction and
intervention. Deep learning is a representation learning method that consists
of layers that transform the data non-linearly, thus, revealing hierarchical
relationships and structures. In this review we survey deep learning
application papers that use structured data, signal and imaging modalities from
cardiology. We discuss the advantages and limitations of applying deep learning
in cardiology that also apply in medicine in general, while proposing certain
directions as the most viable for clinical use.Comment: 27 pages, 2 figures, 10 table
Artificial Intelligence in Assessing Cardiovascular Diseases and Risk Factors via Retinal Fundus Images: A Review of the Last Decade
Background: Cardiovascular diseases (CVDs) continue to be the leading cause
of mortality on a global scale. In recent years, the application of artificial
intelligence (AI) techniques, particularly deep learning (DL), has gained
considerable popularity for evaluating the various aspects of CVDs. Moreover,
using fundus images and optical coherence tomography angiography (OCTA) to
diagnose retinal diseases has been extensively studied. To better understand
heart function and anticipate changes based on microvascular characteristics
and function, researchers are currently exploring the integration of AI with
non-invasive retinal scanning. Leveraging AI-assisted early detection and
prediction of cardiovascular diseases on a large scale holds excellent
potential to mitigate cardiovascular events and alleviate the economic burden
on healthcare systems. Method: A comprehensive search was conducted across
various databases, including PubMed, Medline, Google Scholar, Scopus, Web of
Sciences, IEEE Xplore, and ACM Digital Library, using specific keywords related
to cardiovascular diseases and artificial intelligence. Results: A total of 87
English-language publications, selected for relevance were included in the
study, and additional references were considered. This study presents an
overview of the current advancements and challenges in employing retinal
imaging and artificial intelligence to identify cardiovascular disorders and
provides insights for further exploration in this field. Conclusion:
Researchers aim to develop precise disease prognosis patterns as the aging
population and global CVD burden increase. AI and deep learning are
transforming healthcare, offering the potential for single retinal image-based
diagnosis of various CVDs, albeit with the need for accelerated adoption in
healthcare systems.Comment: 40 pages, 5 figures, 2 tables, 91 reference
Partially Lazy Classification of Cardiovascular Risk via Multi-way Graph Cut Optimization
Cardiovascular disease (CVD) is considered a leading cause of human mortality with rising trends worldwide. Therefore, early identification of seemingly healthy subjects at risk is a priority. For this purpose, we propose a novel classification algorithm that provides a sound individual risk prediction, based on a non-invasive assessment of retinal vascular function. so-called lazy classification methods offer reduced time complexity by saving model construction time and better adapting to newly available instances, when compared to well-known eager methodS. Lazy methods are widely used due to their simplicity and competitive performance. However, traditional lazy approaches are more vulnerable to noise and outliers, due to their full reliance on the instances' local neighbourhood for classification. In this work, a learning method based on Graph Cut Optimization called GCO mine is proposed, which considers both the local arrangements and the global structure of the data, resulting in improved performance relative to traditional lazy methodS. We compare GCO mine coupled with genetic algorithms (hGCO mine) with established lazy and eager algorithms to predict cardiovascular risk based on Retinal Vessel Analysis (RVA) data. The highest accuracy of 99.52% is achieved by hGCO mine. The performance of GCO mine is additionally demonstrated on 12 benchmark medical datasets from the UCI repository. In 8 out of 12 datasets, GCO mine outperforms its counterpartS. GCO mine is recommended for studies where new instances are expected to be acquired over time, as it saves model creation time and allows for better generalization compared to state of the art methodS
Cardiovascular Risk Stratification in Diabetic Retinopathy via Atherosclerotic Pathway in COVID-19/non-COVID-19 Frameworks using Artificial Intelligence Paradigm: A Narrative Review
Diabetes is one of the main causes of the rising cases of blindness in adults. This microvascular complication of diabetes is termed diabetic retinopathy (DR) and is associated with an expanding risk of cardiovascular events in diabetes patients. DR, in its various forms, is seen to be a powerful indicator of atherosclerosis. Further, the macrovascular complication of diabetes leads to coronary artery disease (CAD). Thus, the timely identification of cardiovascular disease (CVD) complications in DR patients is of utmost importance. Since CAD risk assessment is expensive for lowincome countries, it is important to look for surrogate biomarkers for risk stratification of CVD in DR patients. Due to the common genetic makeup between the coronary and carotid arteries, lowcost, high-resolution imaging such as carotid B-mode ultrasound (US) can be used for arterial tissue characterization and risk stratification in DR patients. The advent of artificial intelligence (AI) techniques has facilitated the handling of large cohorts in a big data framework to identify atherosclerotic plaque features in arterial ultrasound. This enables timely CVD risk assessment and risk stratification of patients with DR. Thus, this review focuses on understanding the pathophysiology of DR, retinal and CAD imaging, the role of surrogate markers for CVD, and finally, the CVD risk stratification of DR patients. The review shows a step-by-step cyclic activity of how diabetes and atherosclerotic disease cause DR, leading to the worsening of CVD. We propose a solution to how AI can help in the identification of CVD risk. Lastly, we analyze the role of DR/CVD in the COVID-19 framework
- …